-+ 0.00%
-+ 0.00%
-+ 0.00%

ACTUATE THERAPEUTICS ANNOUNCES ASCO POSTER PRESENTATIONS DEMONSTRATING COMPELLING CLINICAL AND BIOMARKER DATA FOR ELRAGLUSIB IN FIRST-LINE METASTATIC PANCREATIC CANCER

Reuters·06/01/2026 11:00:02

Please log in to view news